The changing epidemiology of resistance.
暂无分享,去创建一个
[1] Y. Carmeli,et al. First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States , 2008, Antimicrobial Agents and Chemotherapy.
[2] P. Hawkey,et al. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK. , 2004, The Journal of antimicrobial chemotherapy.
[3] 矢野 寿一. Plasmid-encoded metallo-β-lactamase(IMP-6)conferring resistance to carbapenems,especially meropenem , 2002 .
[4] T. Walsh. Clinically significant carbapenemases: an update , 2008, Current opinion in infectious diseases.
[5] P. Courvalin,et al. Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Vietnam , 2002, Antimicrobial Agents and Chemotherapy.
[6] Y. Arakawa,et al. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. , 2000, FEMS microbiology letters.
[7] J. Wu,et al. Identification of a Plasmid Encoding SHV-12, TEM-1, and a Variant of IMP-2 Metallo-β-Lactamase, IMP-8, from a Clinical Isolate of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[8] Y. Carmeli,et al. CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum Beta-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel , 2005, Antimicrobial Agents and Chemotherapy.
[9] P. Hawkey. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[10] M. Souli,et al. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] A. Carattoli,et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. , 2008, The Journal of antimicrobial chemotherapy.
[12] M. Kaufmann,et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. , 2008, The Journal of antimicrobial chemotherapy.
[13] P. Nordmann,et al. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. , 2009, Current medicinal chemistry.
[14] E. Bouza,et al. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. , 2008, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[15] S. Iyobe,et al. Detection of a Variant Metallo-β-Lactamase, IMP-10, from Two Unrelated Strains of Pseudomonas aeruginosa and an Alcaligenes xylosoxidans Strain , 2002, Antimicrobial Agents and Chemotherapy.
[16] E. Wellington,et al. Incidence of Class 1 Integrons in a Quaternary Ammonium Compound-Polluted Environment , 2005, Antimicrobial Agents and Chemotherapy.
[17] T. Sawai,et al. Amino Acid Substitutions in a Variant of IMP-1 Metallo-β-Lactamase , 2000, Antimicrobial Agents and Chemotherapy.
[18] Ronald N. Jones,et al. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007). , 2008, Microbial drug resistance.
[19] G. Cornaglia,et al. Characterization of the Metallo-β-Lactamase Determinant of Acinetobacter baumannii AC-54/97 Reveals the Existence of blaIMP Allelic Variants Carried by Gene Cassettes of Different Phylogeny , 2000, Antimicrobial Agents and Chemotherapy.
[20] M. M. Rodríguez,et al. Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals. , 2003, Antimicrobial agents and chemotherapy.
[21] J. Iredell,et al. Dominance of blaCTX-M within an Australian Extended-Spectrum β-Lactamase Gene Pool , 2008, Antimicrobial Agents and Chemotherapy.
[22] A. Apisarnthanarak,et al. Molecular Characterization and Epidemiology of Extended-Spectrum- β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic , 2008, Antimicrobial Agents and Chemotherapy.
[23] F. Yoshimura,et al. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance , 1994, Antimicrobial Agents and Chemotherapy.
[24] L. Peixe,et al. Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. , 2002, FEMS microbiology letters.
[25] I. Wiegand,et al. First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. , 2006, International journal of antimicrobial agents.
[26] Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.
[27] J. Saunders,et al. Mosaic plasmids and mosaic replicons: evolutionary lessons from the analysis of genetic diversity in IncFII-related replicons. , 2000, Microbiology.
[28] R. Cantón,et al. The CTX-M β-lactamase pandemic , 2006 .
[29] F. Vandenesch,et al. Global Distribution of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus aureus, 2006 , 2007, Emerging infectious diseases.
[30] A. Armaganidis,et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. , 2007, The Journal of antimicrobial chemotherapy.
[31] S. Nair,et al. Variation in Salmonella enterica Serovar Typhi IncHI1 Plasmids during the Global Spread of Resistant Typhoid Fever , 2008, Antimicrobial Agents and Chemotherapy.
[32] R. Leplae,et al. A first global analysis of plasmid encoded proteins in the ACLAME database. , 2006, FEMS microbiology reviews.
[33] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[34] J. Patel,et al. Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid , 2008, Journal of Clinical Microbiology.
[35] Susan K. Johnson,et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.
[36] S. Rehm. Staphylococcus aureus: the new adventures of a legendary pathogen. , 2008, Cleveland Clinic journal of medicine.
[37] H. Maltezou,et al. Community-acquired methicillin-resistant Staphylococcus aureus infections. , 2006, International journal of antimicrobial agents.
[38] L. Martínez-Martínez,et al. Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases in Spain , 2005, Antimicrobial Agents and Chemotherapy.
[39] W. Witte,et al. Methicillin-Resistant and -Susceptible Staphylococcus aureus Strains of Clonal Lineages ST398 and ST9 from Swine Carry the Multidrug Resistance Gene cfr , 2008, Antimicrobial Agents and Chemotherapy.
[40] Mirjam Feldkamp,et al. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus , 2008, Proceedings of the National Academy of Sciences.
[41] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[42] Yunsong Yu,et al. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. , 2007, The Journal of infection.
[43] P. Bradford,et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] Richard A. Moore,et al. Nosocomial Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa with a New blaIMP Allele, blaIMP-7 , 2002, Antimicrobial Agents and Chemotherapy.
[45] N. Woodford,et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. , 2008, The Journal of antimicrobial chemotherapy.
[46] V. Ensor,et al. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2006, The Journal of antimicrobial chemotherapy.
[47] Xianghui Liang,et al. Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. , 2009, The Journal of antimicrobial chemotherapy.
[48] A. Oliver,et al. Characterization of a Large Outbreak by CTX-M-1-Producing Klebsiella pneumoniae and Mechanisms Leading to In Vivo Carbapenem Resistance Development , 2006, Journal of Clinical Microbiology.
[49] R. Finch,et al. Tigecycline: in-vitro performance as a predictor of clinical efficacy. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[50] E. Gotuzzo,et al. Rapid Dissemination and Diversity of CTX-M Extended-Spectrum β-Lactamase Genes in Commensal Escherichia coli Isolates from Healthy Children from Low-Resource Settings in Latin America , 2007, Antimicrobial Agents and Chemotherapy.
[51] M. Pimkin,et al. Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals , 2003, Antimicrobial Agents and Chemotherapy.
[52] D. Spelman,et al. Large Outbreak of Infection and Colonization with Gram-Negative Pathogens Carrying the Metallo-β-Lactamase Gene bla IMP-4 at a 320-Bed Tertiary Hospital in Australia , 2007, Infection Control & Hospital Epidemiology.
[53] D. Church,et al. Molecular Epidemiology of CTX-M-Producing Escherichia coli in the Calgary Health Region: Emergence of CTX-M-15-Producing Isolates , 2007, Antimicrobial Agents and Chemotherapy.
[54] Z. Daoud,et al. Countrywide Spread of Community- and Hospital-Acquired Extended-Spectrum β-Lactamase (CTX-M-15)-Producing Enterobacteriaceae in Lebanon , 2005, Journal of Clinical Microbiology.
[55] P M Bennett,et al. Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. , 2005, The Journal of antimicrobial chemotherapy.
[56] C. Salgado,et al. Community-acquired methicillin-resistant Staphylococcus aureus. , 2004, JAMA.
[57] K. Klugman. The successful clone: the vector of dissemination of resistance in Streptococcus pneumoniae. , 2002, The Journal of antimicrobial chemotherapy.
[58] P. Nordmann,et al. Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[59] L. Rice,et al. Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases , 2003, Antimicrobial Agents and Chemotherapy.
[60] L. Wang,et al. The prevalence of plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China , 2008, European Journal of Clinical Microbiology & Infectious Diseases.
[61] J. Lavigne,et al. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. , 2008, The Journal of antimicrobial chemotherapy.
[62] Ronald N. Jones,et al. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). , 2006, Diagnostic microbiology and infectious disease.
[63] George A. Jacoby,et al. AmpC β-Lactamases , 2009, Clinical Microbiology Reviews.
[64] D. Livermore,et al. A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum beta-lactamases. , 2007, The Journal of antimicrobial chemotherapy.
[65] Kristine M Hujer,et al. Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases. , 2003, Antimicrobial agents and chemotherapy.
[66] G Prats,et al. Prevalence of qnr genes among extended-spectrum beta-lactamase-producing enterobacterial isolates in Barcelona, Spain. , 2008, The Journal of antimicrobial chemotherapy.
[67] N. Woodford,et al. CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.
[68] Ronald N. Jones,et al. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). , 2005, Diagnostic microbiology and infectious disease.
[69] G. Rossolini,et al. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. , 2005, International journal of antimicrobial agents.
[70] Stephan Harbarth,et al. Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes , 2004, Emerging infectious diseases.
[71] Ronald N. Jones,et al. Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene , 2007, Antimicrobial Agents and Chemotherapy.
[72] K. Drlica,et al. Fluoroquinolones: action and resistance. , 2003, Current topics in medicinal chemistry.
[73] D. Robinson,et al. Evolutionary Models of the Emergence of Methicillin-Resistant Staphylococcus aureus , 2003, Antimicrobial Agents and Chemotherapy.
[74] J. Heritage,et al. Three Cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China , 2002, Antimicrobial Agents and Chemotherapy.
[75] G. Arlet,et al. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). , 2008, Pathologie-biologie.
[76] Arjun Srinivasan,et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. , 2005, The New England journal of medicine.
[77] M. Hynes,et al. bla IMP-9 and Its Association with Large Plasmids Carried by Pseudomonas aeruginosa Isolates from the People's Republic of China , 2006, Antimicrobial Agents and Chemotherapy.
[78] Neil Woodford,et al. Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center , 2004, Antimicrobial Agents and Chemotherapy.
[79] Wonkeun Song,et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea , 2009, Journal of medical microbiology.
[80] A. Sheets. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections , 2006 .
[81] E. Sadowy,et al. Molecular Survey of β-Lactamases Conferring Resistance to Newer β-Lactams in Enterobacteriaceae Isolates from Polish Hospitals , 2008, Antimicrobial Agents and Chemotherapy.